5
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Effects of dsip, 5-HTP and serotonin on the lymphokine system: A preliminary study

, &
Pages 185-197 | Received 01 Jul 1986, Accepted 28 Jul 1986, Published online: 07 Jul 2009
 

Abstract

Short term effects of the sleep promoting substances DSIP, 5-HTP and 5-HT on the function of the lymphokine system were studied 10 and 30 min after treatment. DSIP treatment after 10 and 30 min caused a significant decrease in IL-3 and CSF levels, response to CSF-1 and CSF-GM, IL-2 level, number of IL-2 receptors and in cell proliferation. DSIP initially induced (after 10 min) a decrease to be followed (after 30 min) by an increase in IL-1 level. Ten minutes after 5-HTP treatment a decrease was found in all parameter tests, except in IL-3 and in CSF secretion. 5-HT treatment was able to induce an increase in IL-3 level, a decrease in response to IL-2 receptors and proliferation, 10 min after treatment. Thirty minutes after treatment, only IL-3 and IL-2 levels were reduced. These results showed that sleep promoting substances had an effect on the lymphokines system, that DSIP was the most potent agent, that immunological changes occur before physiological or behavioral signs. The relative weak potency 5-HTP and 5-HT, and the similar pattern of effects between them, may indicate that peripheral events may lead to sleep state.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.